Q1 2017 Holdings
Filed 2017-05-15 | 30 holdings | $86.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $54.8M | 4,260,836 | 63.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $31.2M | 1,804,675 | 36.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $84.1K | 2,102,280 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $58.2K | 7,990,572 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $48.2K | 1,738,600 | 0.1% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $39.9K | 2,336,609 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $29.9K | 1,387,853 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $25.4K | 7,866,108 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $24.7K | 2,763,086 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $18.8K | 4,479,691 | 0.0% |
| Biolinerx LTD Sponsored | SPONSORED ADR | 09071M106 | $16.8K | 17,500,000 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $16.2K | 1,760,489 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $15.3K | 2,826,282 | 0.0% |
| Achillion Pharmaceuticals Inc COM(ACHNEUR) | COM | 00448Q201 | $13.8K | 3,285,400 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $13.5K | 320,000 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $13.0K | 3,133,224 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.8K | 2,949,794 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $10.7K | 1,502,800 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $8.9K | 1,945,245 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $8.4K | 1,233,976 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $7.8K | 7,400,128 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $6.3K | 1,540,323 | 0.0% |
| Orexigen Therapeutics Inc | NOTE 2.750% | 686164AB0 | $5.5K | $10,000,000 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $5.4K | 1,864,474 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $5.4K | 1,108,433 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.0K | 1,917,033 | 0.0% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $3.4K | 8,052,073 | 0.0% |
| Orexigen Therapeutics Inc | COM NEW | 686164302 | $2.5K | 734,976 | 0.0% |
| Pain Therapeutics Inc | COM | 69562K100 | $2.0K | 2,278,552 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $1.0K | 623,000 | 0.0% |